PFE stock · PLUS stock

PFE vs PLUS

Pfizer Inc (PFE) versus ePlus inc (PLUS) — a side-by-side from cached financials, not a winner call.

Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.

ePlus inc (PLUS) is a software - application company listed on NASDAQ.

Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.

Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.

PFE currently screens at market cap $147.73B and trailing P/E 19.8. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.

Not investment advice. Open the PFE and PLUS stock pages for the full models.

Not investment advice.

Popular Stock Comparisons